Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice

Experimental Hematology

Volumn 32, Issue 4, 2004, Pages 360-364

  Almarza, Elena ^a   Segovia, José Carlos ^a   Guenechea, Guillermo ^a   Gómez, Susana G ^a   Ramírez, Ángel ^a   Bueren, Juan Antonio ^a,b  

^a Gene Therapy Programme   (Spain)

^b CIEMAT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VAV PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL FRACTIONATION; CELL POPULATION; CELL SELECTION; COMPETITIVE ABILITY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LYMPHOID CELL; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; TRANSGENE;

ANIMALS; ANTIGENS, CD4; BONE MARROW CELLS; CELL CYCLE PROTEINS; CLONE CELLS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MULTIPOTENT STEM CELLS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RECOMBINANT FUSION PROTEINS; TRANSGENES;

ANIMALIA; MUS MUSCULUS;

EID: 1642634598     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.01.005     Document Type: Article

References (14)

1. Katzav S., Martin-Zanca D., Barbacid M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:1989;2283-2290.
2. Coppola J., Bryant S., Koda T., Conway D., Barbacid M. Mechanism of activation of the vav protooncogene. Cell Growth Differ. 2:1991;95-105.
3. Adams J.M., Houston H., Allen J., Lints T., Harvey R. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene. 7:1992;611-618.
4. Bustelo X.R., Rubin S.D., Suen K.L., Carrasco D., Barbacid M. Developmental expression of the vav protooncogene. Cell Growth Differ. 4:1993;297-308.
5. Keller G., Kennedy M., Papayannopoulou T., Wiles M.V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol. 13:1993;473-486.
6. Ogilvy S., Elefanty A.G., Visvader J., Bath M.L., Harris A.W., Adams J.M. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood. 91:1998;419-430.
7. Ogilvy S., Metcalf D., Gibson L., Bath M.L., Harris A.W., Adams J.M. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood. 94:1999;1855-1863.
8. Georgiades P., Ogilvy S., Duval H., et al. vavCre Transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis. 34:2002;251-256.
9. Ogilvy S., Metcalf D., Print C.G., Bath M.L., Harris A.W., Adams J.M. Constitutive Bcl-2 expression throughout the hematopoietic compartment affect multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA. 96:1999;14943-14948.
10. de Boer J., Williams A., Skavdis G., et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol. 33:2003;314-325.
11. Hogan B., Beddington R., Constantini F., Lacy E. Microinjecting DNA into pronuclei. Hogan B., Beddington R., Constantini F., Lacy E. Manipulating the Mouse Embryo: a Laboratory Manual. 1994;416 Cold Spring Harbor Press, New York.
12. Rio P., Segovia J.C., Hanenberg H., et al. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice. Blood. 100:2002;2032-2039.
13. Varas F., Bernad A., Almendral J.M., Bueren J.A. Relevance of myeloablative conditioning in the engraftment of limiting numbers of normal and genetically marked lympho-hematopoietic stem cells. Bone Marrow Transplant. 18:1996;981-989.
14. Albella B., Segovia J.C., Guenechea G., Pragnell I.B., Bueren J.A. Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11. Transplantation. 67:1999;1348-1357.